Post-earnings recap
Reported
Tue, May 10, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
13%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bausch Health's earnings report showed a significant miss on EPS, which likely contributed to the sharp decline in stock price. Investors reacted negatively, leading to a 27.13% drop in the stock. The lack of revenue data and management commentary adds uncertainty about the company's performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.19 | N/A | -118.45% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.